Archived Grant Opportunity View - GO1228
Support for Cancer Clinical Trials Program
Important advances in cancer prevention, treatment and care can be made through clinical trials and people diagnosed with cancer will benefit from the outcomes of cancer clinical trials through improved evidence-based, best-practice care.
Industry-independent cancer clinical trials can play an important role in the cancer research landscape because these trials can address important questions in patient treatment and care which may not be of commercial interest to the pharmaceutical industry.
The primary aim of the Support for Cancer Clinical Trials program is to support Multi-site Collaborative Cancer Clinical Trials Groups to develop industry-independent cancer clinical trial protocols to the stage of application for grant funding.
The broader program objectives are to:
- Increase the number of cancer clinical trials conducted in Australia
- Increase the participation in clinical trials by people affected by cancer
- Increase the number of clinical sites actively participating in cancer clinical trials
- Increase the involvement of policy makers, clinicians, researchers and consumers in the development of cancer clinical trials
- Increase National Cancer Cooperative Trials Group participation in national multi-group or international cancer clinical trials in Australia
The outcome of this program is to guide scientific improvements in cancer prevention, treatment and care and in doing so build the evidence-base for best practice cancer care to improve health outcomes for Australian’s affected by cancer.
The following Multi-site Collaborative Cancer Clinical Trials Groups are eligible to apply for targeted competitive funding:
- Australasian Gastro-Intestinal Trials Group;
- Australasian Leukaemia and Lymphoma Group;
- Australasian Lung Cancer Trials Group;
- Australasian Sarcoma Study Group;
- Australia and New Zealand Breast Cancer Trials Group;
- Australia and New Zealand Melanoma Trials Group;
- Australia New Zealand Gynaecological Oncology Group;
- Australian and New Zealand Children’s Haematology and Oncology Group;
- Australian and New Zealand Urogenital and Prostate Cancer Trials Group;
- Cooperative Trials Group for Neuro-Oncology;
- Primary Care Collaborative Cancer Clinical Trials Group
- Psycho-Oncology Co-operative Research Group; and
- Trans-Tasman Radiation Oncology Group.
Applications must satisfy all the requirements set out in the 2018-2021 Support for Cancer Clinical Trials Program Grant Rules.
$19,500,000.00
From $0.00 to $1,500,000.00
Applications must be emailed to: jessie.kiu@canceraustralia.gov.au
The email should quote Support for Cancer Clinical Trials in the subject heading.
Applications should be submitted as one signed copy in PDF format (Filename: Support for Cancer Clinical Trials_Applicant Name) and one MS Office Word format (do not exceed 5MB in size).